These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 19219669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Outcome predictors in cocaine dependence treatment trials.
    Ahmadi J, Kampman K, Dackis C.
    Am J Addict; 2006; 15(6):434-9. PubMed ID: 17182445
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
    Kampman KM, Pettinati HM, Lynch KG, Spratt K, Wierzbicki MR, O'Brien CP.
    Drug Alcohol Depend; 2013 Nov 01; 133(1):94-9. PubMed ID: 23810644
    [Abstract] [Full Text] [Related]

  • 5. A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.
    Pettinati HM, Kampman KM, Lynch KG, Xie H, Dackis C, Rabinowitz AR, O'Brien CP.
    Addict Behav; 2008 May 01; 33(5):651-67. PubMed ID: 18079068
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence.
    Malcolm R, Kajdasz DK, Herron J, Anton RF, Brady KT.
    Drug Alcohol Depend; 2000 Aug 01; 60(2):161-8. PubMed ID: 10940543
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I, Ralevski E, Nich C, Levinson C, Carroll K, Poling J, Rounsaville B, VA VISN I MIRECC Study Group.
    J Clin Psychopharmacol; 2007 Apr 01; 27(2):160-5. PubMed ID: 17414239
    [Abstract] [Full Text] [Related]

  • 9. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.
    Kampman KM, Lynch KG, Pettinati HM, Spratt K, Wierzbicki MR, Dackis C, O'Brien CP.
    Drug Alcohol Depend; 2015 Oct 01; 155():105-10. PubMed ID: 26320827
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reliability and validity of the Cocaine Selective Severity Assessment.
    Kampman KM, Volpicelli JR, McGinnis DE, Alterman AI, Weinrieb RM, D'Angelo L, Epperson LE.
    Addict Behav; 1998 Oct 01; 23(4):449-61. PubMed ID: 9698974
    [Abstract] [Full Text] [Related]

  • 12. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
    Pettinati HM, Kampman KM, Lynch KG, Suh JJ, Dackis CA, Oslin DW, O'Brien CP.
    J Subst Abuse Treat; 2008 Jun 01; 34(4):378-90. PubMed ID: 17664051
    [Abstract] [Full Text] [Related]

  • 13. Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.
    Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J.
    Addiction; 2016 Aug 01; 111(8):1416-27. PubMed ID: 26948856
    [Abstract] [Full Text] [Related]

  • 14. Naltrexone treatment of comorbid alcohol and cocaine use disorders.
    Hersh D, Van Kirk JR, Kranzler HR.
    Psychopharmacology (Berl); 1998 Sep 01; 139(1-2):44-52. PubMed ID: 9768541
    [Abstract] [Full Text] [Related]

  • 15. Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia.
    Batki SL, Leontieva L, Dimmock JA, Ploutz-Snyder R.
    Schizophr Res; 2008 Oct 01; 105(1-3):201-7. PubMed ID: 18701256
    [Abstract] [Full Text] [Related]

  • 16. Alcohol use affects the outcome of treatment for cocaine abuse.
    Mengis MM, Maude-Griffin PM, Delucchi K, Hall SM.
    Am J Addict; 2002 Oct 01; 11(3):219-27. PubMed ID: 12202014
    [Abstract] [Full Text] [Related]

  • 17. Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy.
    Schmitz JM, Stotts AL, Sayre SL, DeLaune KA, Grabowski J.
    Am J Addict; 2004 Oct 01; 13(4):333-41. PubMed ID: 15370932
    [Abstract] [Full Text] [Related]

  • 18. Effects of naltrexone on cue-elicited craving for alcohol and cocaine.
    Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR.
    Drug Alcohol Depend; 1997 Dec 01; 49(1):9-16. PubMed ID: 9476694
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.
    Winhusen T, Somoza E, Ciraulo DA, Harrer JM, Goldsmith RJ, Grabowski J, Coleman FS, Mindrum G, Kahn R, Osman S, Mezinskis J, Li SH, Lewis D, Horn P, Montgomery MA, Elkashef A.
    Drug Alcohol Depend; 2007 Dec 01; 91(2-3):141-8. PubMed ID: 17629631
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
    Kampman KM, Dackis C, Pettinati HM, Lynch KG, Sparkman T, O'Brien CP.
    Addict Behav; 2011 Mar 01; 36(3):217-21. PubMed ID: 21112155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.